Patient P-02179

Synthetic patientMETA-24 · Day 112 · 25–34 · M · baseline S04Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S04

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-10
Treatment adherence-8
GI instability+6

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

44 min

worsening · -1.7 vs previous 14 d

Sleep duration

Wearable

6.9 h

stable · -0.2 vs previous 14 d

Energy level

Daily log

6.9/10

stable · +0.1 vs previous 14 d

Steps

Wearable

4,235

worsening · -408 vs previous 14 d

GI burden

Companion

20.2/100

worsening · +7.4 vs previous 14 d

Adherence

Companion

91.7 %

stable · +1.8 vs previous 14 d

Sleep quality

Wearable

56.5/100

worsening · -4.3 vs previous 14 d

Glucose, CGM daily mean

CGM

120 mg/dL

worsening · +7.0 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 91 from the failing basin, 9 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +12.6
Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -7.2 next day

Main detractors to watch

Histamine load
perturbation · steering -11
FUT2 non-secretor
hidden · steering -10.6
Bacteroides fragilis elevated
hidden · steering -7.4
Poor-sleep week
perturbation · steering -3
Histamine load
detractor · GI +6 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-7.2supporter · 95%
Histamine load
+6detractor · 95%
Ultra-processed food
+2no signal · 39%
Dietary fat load
+1.7no signal · 34%
Insoluble fibre
+1.5no signal · 28%
Alcohol
+1.4no signal · 26%
Caffeine
+1.3no signal · 25%
Simple carbohydrates
-1.1no signal · 19%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.4 · butyrate capacity 54/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 60 ms
Sleep: 6.6 h
Steps: 3,897
Resting HR: 69 bpm

Daily log: GI score 20, nutritional resilience 68, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	50%	S01	AD-05	no change	79
P-02277	46%	S05	AD-05	improved	92
P-02282	42%	S01	BR-03	no change	88
P-02013	41%	S14	BR-03	no change	94
P-02193	40%	S11	CR-01	improved	87
P-02354	31%	S01	CR-01	improved	78
P-02565	48%	S09	DT-01	no change	79
P-02081	43%	S20	DT-01	no change	88
P-02337	43%	S18	DT-01	no change	100
P-02249	39%	S09	DT-01	improved	100
P-02462	32%	S12	DT-01	improved	65
P-02218	30%	S01	DT-01	improved	61